Fortis Healthcare sets dividend record date, outlines TDS norms

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Fortis Healthcare has fixed July 24, 2026, as the record date for a final dividend of ₹1 per share, subject to AGM approval. The company outlined TDS rates of 10% for residents with valid PAN and 20% for non-residents or those with inoperative PAN. Shareholders must submit declarations for exemptions or lower tax by August 5, 2026.

powered bylight_fuzz_icon
45379015

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited has fixed Friday, July 24, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹1 per equity share. The dividend, equivalent to 10% of the face value of ₹10 each, is recommended for the financial year 2025-26 and is subject to the approval of members at the 30th Annual General Meeting scheduled for Tuesday, August 11, 2026. The company has intimated that the dividend will be paid subject to the deduction of Tax at Source (TDS) in accordance with the Income Tax Act, 2025.

The Register of Members and Share Transfer Books will remain closed from Saturday, July 25, 2026, to Tuesday, August 11, 2026. Shareholders are requested to ensure that details such as PAN, residential status, category, and bank account information are updated in their demat accounts or folios by submitting Form ISR-1 to the Registrar and Share Transfer Agent, KFin Technologies Limited. To avail benefits of exemption or lower tax deduction, shareholders must submit necessary declarations and supporting documents on or before August 5, 2026.

Tax Deduction Rates

For resident shareholders, tax will be deducted at 10% if a valid PAN is registered. If the shareholder is a specified person or has provided an inoperative PAN, TDS will be deducted at 20%. Resident individuals are exempt from TDS if the aggregate dividend distributed during the financial year does not exceed ₹10,000. Non-resident shareholders, including Foreign Portfolio Investors, face a withholding tax rate of 20% plus applicable surcharge and cess, unless they opt for benefits under the Double Tax Avoidance Agreement (DTAA).

Shareholder Category Applicable TDS Rate Conditions
Resident (Valid PAN) 10% Valid PAN registered
Resident (Inoperative/No PAN) 20% Specified person or inoperative PAN
Non-Resident 20% + surcharge + cess Unless DTAA benefit is claimed
Resident Individual Nil Dividend ≤ ₹10,000 per year

Compliance and Submission

Shareholders seeking lower or nil TDS must submit self-declarations and documents via the weblink provided by KFin Technologies or via email. Non-resident shareholders claiming DTAA benefits must provide a Tax Residence Certificate, Form 41, and a self-declaration certifying tax residency and eligibility. The company emphasized that it will rely on data available with the depositories and the RTA as of the record date, and no requests for revision of TDS returns will be entertained.

The intimation was made in compliance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.65%+1.67%-2.61%+0.48%+0.96%+229.92%

How might the announcement of this final dividend influence Fortis Healthcare's stock liquidity leading up to the record date?

Could this dividend payout signal a shift in Fortis Healthcare's capital allocation strategy for FY 2026-27?

What impact will the updated Income Tax Act, 2025 provisions have on foreign investor appetite for the stock?

Fortis Healthcare 30th AGM on Aug 11, 2026

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Fortis Healthcare Limited will hold its 30th Annual General Meeting on August 11, 2026, through video conferencing. The agenda includes adopting financial statements for FY 2025-26 and approving a final dividend of ₹1 per share. Special resolutions cover the re-appointment of Dr. Ashutosh Raghuvanshi as MD & CEO, remuneration for Independent Directors, and cost auditor ratification. The company reported a consolidated net profit of ₹1,06,418.79 lacs for the year.

powered bylight_fuzz_icon
45917164

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited will convene its 30th Annual General Meeting (AGM) on Tuesday, August 11, 2026, at 12:00 hours IST through Video Conferencing and Other Audio Visual Means (VC/OAVM). The meeting will transact both ordinary and special business as outlined in the AGM notice, with members participating remotely counted for quorum purposes under Section 103 of the Companies Act, 2013. The AGM notice and Annual Report for FY 2025-26 were dispatched on July 17, 2026 to shareholders with registered email addresses.

Key AGM Schedule

The following table summarises the critical dates and timelines for the 30th AGM:

Event: Date Time (IST)
Record Date for Dividend Friday, July 24, 2026 Not Applicable
Cut-off Date for E-voting Tuesday, August 4, 2026 Not Applicable
E-voting Commencement Thursday, August 6, 2026 9:00 A.M.
E-voting End Monday, August 10, 2026 5:00 P.M.
30th AGM Tuesday, August 11, 2026 12:00 P.M.
Final Dividend Payment (on or before) Wednesday, September 9, 2026
Results Declaration (on or before) Thursday, August 13, 2026 6:00 P.M.
Speaker Registration Window July 21, 2026 – August 6, 2026

Ordinary Business

Shareholders will be asked to receive and adopt the audited standalone and consolidated financial statements for the year ended March 31, 2026, along with the Board and Auditors' reports. The Board has recommended a final dividend of ₹1 per equity share for FY 2025-26, subject to shareholder approval. The record date for dividend payment is Friday, July 24, 2026, and the Register of Members will remain closed from July 25, 2026 to August 11, 2026 (both days inclusive).

The meeting will also consider the re-appointment of Mr. Ashok Pandit (DIN: 09279899) and Dr. Prem Kumar Nair (DIN: 10348774), Non-Executive Non-Independent Directors retiring by rotation, both of whom are eligible and have offered themselves for re-appointment.

Special Business

The AGM agenda includes four special resolutions. The following table outlines the key proposals:

Resolution: Details
Item 5 – Cost Auditor Remuneration Ratification of remuneration of up to ₹2,95,000 to M/s. Jitender, Navneet & Co. (Firm Reg. No. 000119) for FY ended March 31, 2026
Item 6 – Independent Director Commission Approval to pay commission to Independent Directors for three years effective April 1, 2027 to March 31, 2030; up to ₹77,17,500 per annum per Independent Director and up to ₹1,95,00,000 per annum to the Chairman (if Independent Director)
Item 7 – Leo Puri Remuneration Approval for payment of commission of ₹1,95,00,000 to Mr. Leo Puri (DIN: 01764813), Non-Executive Independent Chairperson, for FY 2025-26, which exceeds 50% of total annual remuneration payable to all Non-Executive Directors
Item 8 – MD & CEO Re-appointment Re-appointment of Dr. Ashutosh Raghuvanshi (DIN: 02775637) as Managing Director & CEO for two years effective March 19, 2027, with salary and perquisites of up to ₹11,23,46,000 per annum

Financial Performance Highlights (FY 2025-26)

The following financial results, as disclosed in the AGM notice, underpin the remuneration proposals:

Particulars: Standalone (₹ in Lacs) Consolidated (₹ in Lacs)
Turnover 1,79,249.50 9,12,784.18
Other Income 16,518.17 5,066.16
Net Profit After Tax 23,034.29 1,06,418.79

E-Voting and Participation

The remote e-voting facility is provided by National Securities Depository Limited (NSDL). Members holding shares as of the cut-off date of August 4, 2026 are eligible to vote electronically. Shareholders who have cast their votes remotely may attend the AGM via VC/OAVM but will not be permitted to vote again during the meeting. Mr. Mukesh Agarwal (C.P. No. 3851) of M/s Mukesh Agarwal & Co., Practicing Company Secretaries, has been appointed as the Scrutinizer. The AGM is being held in compliance with the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and applicable MCA and SEBI circulars.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.65%+1.67%-2.61%+0.48%+0.96%+229.92%

What strategic initiatives is Fortis Healthcare pursuing to sustain the consolidated net profit growth of ₹1,06,418.79 lacs?

How will the re-appointment of Dr. Ashutosh Raghuvanshi as MD & CEO influence the company's expansion plans over the next two years?

What impact will the approved commission for Independent Directors have on shareholder sentiment and corporate governance standards?

More News on Fortis Healthcare

1 Year Returns:+0.96%